Safety of reduced-antigen-content tetanus–diphtheria–acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis–containing vaccine

This publication has 12 references indexed in Scilit:

• Acellular Pertussis Vaccine Booster Combined With Diphtheria and Tetanus Toxoids for Adolescents
  Published by American Academy of Pediatrics (AAP) ,2006
• Combined Tetanus, Diphtheria, and 5-Component Pertussis Vaccine for Use in Adolescents and Adults
  JAMA, 2005
• Overview of Pertussis
  The Pediatric Infectious Disease Journal, 2005
• Effects of lowering the aluminium content of a dTpa vaccine on its immunogenicity and reactogenicity when given as a booster to adolescents
  Vaccine, 2005
• Extensive Limb Swelling after Immunization: Reports to the Vaccine Adverse Event Reporting System
  Clinical Infectious Diseases, 2003
• Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines
  Seminars in Pediatric Infectious Diseases, 2003
• Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration
  Vaccine, 2001
• A Randomized Clinical Trial of Acellular Pertussis Vaccines in Healthy Adults: Dose‐Response Comparisons of 5 Vaccines and Implications for Booster Immunization
  The Journal of Infectious Diseases, 1999
• Changing Epidemiology of Pertussis in the United States: Increasing Reported Incidence Among Adolescents and Adults, 1990‐1996
  Clinical Infectious Diseases, 1999
• Acellular Pertussis Vaccines
  Drug Safety, 1996